The ENDO/MULTI bundle is the pinnacle of our comprehensive offerings, encompassing various diagnostic assessments from head to toe. Not only does it feature all the critical components found in the PRIMARY bundle, including the highly effective ANS/HRV, DPN, PAD, assessments, but it also goes the extra mile by introducing the diabetic retinopathy exam (DRE). This particular examination is highly sought-after and endorsed by various insurance payors, making it a pivotal addition to the Diabetes Testing Centers™ suite of services. The DRE plays a crucial role in diabetes screening, aligning with NCQA HEDIS rating plans, Medicare Advantage STAR, and Medicare quality rating programs. By incorporating the DRE into routine check-ups, healthcare providers can identify potential retinal issues early, facilitating timely interventions to prevent the onset of blindness. 

One of the remarkable aspects of the DRE is its ability to offer patients an opportunity to qualify for financial incentives beyond conventional reimbursements. This approach not only ensures top-tier healthcare but also eliminates the need for patients to go through the inconvenience of getting their eyes dilated or scheduling separate appointments with eye care specialists. By making these services readily available within primary care providers and multi-specialist offices, we have streamlined the process for patients, enabling them to undergo their annual retinal exams conveniently and efficiently. This integration fosters a patient-centric approach to diabetes care, promoting early detection and reducing the burden on diabetes patients.

The PODIATRY bundle represents a meticulously designed package focusing on the critical aspects of lower-extremity health in diabetic patients. At its core lies the remarkable Diabetic Neuropathy Device™, a groundbreaking innovation in diabetes care. This device has the unique capability to identify and measure both small and large nerve fibers, providing a comprehensive neuropathy assessment. By harnessing its power, healthcare providers can gain valuable insights into the patient's nerve health, allowing for early detection and intervention in cases of neuropathy. 

Complementing this cutting-edge technology, the PODIATRY bundle also integrates the TruPAD™, an advanced tool specializing in peripheral arterial disease (PAD) testing. Combining these two devices empowers healthcare professionals with a comprehensive set of tools to diagnose and manage neuropathy and vascular issues. This proactive approach to patient care not only enhances the quality of healthcare provided but also plays a significant role in reducing the risk of severe complications that often accompany diabetes. By embracing the PODIATRY bundle, healthcare providers are better equipped to safeguard their patients' lower-extremity health, contributing to improved patient outcomes and overall well-being.

Last, UltraMIST® provides numerous wound care benefits for podiatrists and their patients. Its targeted therapeutic ultrasound waves promote tissue repair, reduce inflammation and accelerate wound healing. This cutting-edge technology offers a non-invasive and pain-free solution that can be used on a range of wound types, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, and surgical wounds. With its advanced features and precision, UltraMIST® provides podiatrists with a powerful tool to enhance overall foot health and improve patient outcomes.